SCHEMBL2640844

SCHEMBL2640844

OC=CCc1cccc(Cn2cccn2)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 2/20 0.56
▸ TSHR P16473 2/20 0.51
▸ KMT2A Q03164 2/20 0.51
▸ MEN1 O00255 1/20 0.51
▸ GLS O94925 3/20 0.46
▸ PRKACA P17612 1/20 0.43
▸ PRKACG P22612 1/20 0.43
▸ PRKACB P22694 1/20 0.43
▸ HDAC1 Q13547 1/20 0.43
▸ HDAC6 Q9UBN7 1/20 0.43
▸ MAPT P10636 3/20 0.42
▸ GAA P10253 2/20 0.42
▸ ALOX15 P16050 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ NOS3 P29474 1/20 0.42
▸ NOS1 P29475 1/20 0.42
▸ GRK6 P43250 1/20 0.41
▸ USP2 O75604 2/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14256403 0.84 HTT (0.68) HTTTSHRKMT2AMEN1GLS
SCHEMBL19920010 0.83 HTT (0.60) HTTTSHRKMT2AMEN1GLS
SCHEMBL14987117 0.80 HTT (0.63) HTTTSHRKMT2AMEN1GLS
SCHEMBL13933220 0.78 HTT (0.60) HTTTSHRKMT2AMEN1GLS
SCHEMBL110733 0.76 HTT (0.59) HTTTSHRKMT2AMEN1GLS
SCHEMBL14987118 0.76 HTT (0.59) HTTTSHRKMT2AMEN1GLS
SCHEMBL29809114 0.76 HTT (0.59) HTTTSHRKMT2AMEN1GLS
SCHEMBL27729369 0.76 HTT (0.63) HTTTSHRKMT2AMEN1GLS
SCHEMBL8404968 0.75 CYP11B1 (0.67) MAPTCYP11B1CYP11B2
SCHEMBL15081591 0.75 HTT (0.61) HTTTSHRKMT2AMEN1GLS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103003266-A Hydroxyalkylbenzylpyrazoles and their use for the treatment of hyperproliferative and angiogenic diseases BAYER IP GMBH 2013-03-27 — — CN disclosed
EP-2569309-A1 HYDROXYALKYL BENZYL PYRAZOLES, AND USE THEREOF FOR THE TREATMENT OF HYPERPROLIFERATIVE AND ANGIOGENIC DISEASES Bayer Intellectual Property GmbH (DE) 2013-03-20 — — EP disclosed
WO-2011141325-A1 HYDROXYALKYL BENZYL PYRAZOLES, AND USE THEREOF FOR THE TREATMENT OF HYPERPROLIFERATIVE AND ANGIOGENIC DISEASES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2011-11-17 — — WO disclosed
Send feedback